id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
ajlm-1899	Nanyeenya, Nicholus; Kiwanuka, Noah; Nakanjako, Damalie; Nakigozi, Gertrude; Kibira, Simon P.S.; Nabadda, Susan; Kiyaga, Charles; Sewanyana, Isaac; Nasuuna, Esther; Makumbi, Fredrick	Low-level viraemia: An emerging concern among people living with HIV in Uganda and across sub-Saharan Africa	2022		.htm	text/html	4609	250	50	Using 1000 copies/mL as a threshold ignores people living with HIV who have low-level viraemia (LLV; HIV VL of at least 50 copies/mL but less than 1000 copies/mL). These include patient monitoring involving clinical events and adherence monitoring, immunological monitoring involving CD4 cell count, and virologic monitoring comprising HIV VL testing.11, 12 Virologic monitoring Virologic monitoring which comprises HIV VL testing is the preferred way of monitoring treatment outcomes in people living with HIV on ART, and WHO recommends use of a threshold of 1000 copies/mL to determine VL non-suppression, indicative of either poor drug adherence or virologic failure.6 However, the United States Centers for Disease Control and Prevention and International Association of Providers of AIDS Care recommend a threshold of 200 copies/mL for VL non-suppression.13,	cache/ajlm-1899.htm	txt/ajlm-1899.txt